Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. [electronic resource]
Producer: 19940421Description: S19-31 p. digitalISSN:- 0362-5664
- Anti-Anxiety Agents
- Antidepressive Agents -- therapeutic use
- Benzodiazepines -- therapeutic use
- Biomarkers -- analysis
- Blood Platelets -- cytology
- Body Temperature -- drug effects
- Cell Size -- drug effects
- Depressive Disorder -- drug therapy
- Double-Blind Method
- Down-Regulation -- drug effects
- Fenfluramine -- therapeutic use
- Humans
- Neurosecretory Systems -- drug effects
- Nortriptyline -- therapeutic use
- Receptors, Serotonin -- classification
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.